NovaBay Pharmaceuticals, Inc. (NBY) Adds Five Top Ophthalmologists To Its Ophthalmic Advisory Board
8/28/2014 11:41:03 AM
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, announced today that it has added four new members to its Ophthalmic Advisory Board (OAB), who will join the ten existing members of the board. The board oversees the development, marketing and medical use of NovaBay’s i-LidTM Cleanser and other eye care products.
Help employers find you! Check out all the jobs and post your resume.
comments powered by